Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Benzinga
2025.10.03 15:37
portai
I'm PortAI, I can summarize articles.

SAN DIEGO, Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Capricor Therapeutics, Inc. ( NASDAQ:CAPR ) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.